{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:02:57Z","timestamp":1784314977379,"version":"3.55.0"},"reference-count":119,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"name":"Lega Italiana per la lotta contro Tumori"},{"name":"Italian Ministry of University and Research","award":["PRIN2022"],"award-info":[{"award-number":["PRIN2022"]}]},{"name":"Italian Ministry of University and Research","award":["IG2025"],"award-info":[{"award-number":["IG2025"]}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004271","name":"Sapienza","doi-asserted-by":"publisher","award":["RM1241905BB85097"],"award-info":[{"award-number":["RM1241905BB85097"]}],"id":[{"id":"10.13039\/501100004271","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,6]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Systemic lupus erythematosus (SLE) is a heterogeneous autoimmune disease driven by immune dysregulation, chronic inflammation, and loss of immune tolerance. Increasing evidence suggests that non-coding RNAs (ncRNAs), including microRNAs, long non-coding RNAs, and circular RNAs, are involved in the fine regulation of immune responses, epigenetic changes, and cytokine signaling in SLE. Their altered expression has been associated with disease activity, specific clinical phenotypes, and treatment response, supporting their potential as biomarkers. Epstein\u2013Barr virus (EBV), a long-suspected contributor to SLE, may further shape disease through persistent immune activation, molecular mimicry, and modulation of host ncRNA pathways. In this review, we examine how EBV and ncRNA dysregulation may converge in autoreactive B cells and other immune compartments to promote the loss of tolerance and the development of clinically distinct forms of SLE. We also discuss the implications of this axis for biomarker development and emerging therapeutic strategies, including personalized immune-targeted approaches.<\/jats:p>","DOI":"10.1093\/cei\/uxag040","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:31:13Z","timestamp":1783337473000},"source":"Crossref","is-referenced-by-count":0,"title":["The silent regulators: non-coding RNAs and Epstein\u2013Barr virus at the crossroads of lupus pathogenesis"],"prefix":"10.1093","volume":"220","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8552-4641","authenticated-orcid":false,"given":"Andrea","family":"Picchianti-Diamanti","sequence":"first","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University of Rome, S. Andrea University Hospital , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Rai","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University of Rome, S. Andrea University Hospital , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Mrmi\u0107","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University of Rome, S. Andrea University Hospital , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Marotta","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University of Rome, S. Andrea University Hospital , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenio","family":"Santacroce","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University of Rome, S. Andrea University Hospital , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Alimandi","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University of Rome, S. Andrea University Hospital , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj","family":"Trivedi","sequence":"additional","affiliation":[{"name":"Department of Experimental Medicine, Sapienza University of Rome , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Anastasiadou","sequence":"additional","affiliation":[{"name":"Department of Clinical and Molecular Medicine, Sapienza University of Rome, S. Andrea University Hospital , Rome ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,7,13]]},"reference":[{"key":"2026071714115875500_uxag040-B1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1136\/ard-2022-223035","article-title":"Global epidemiology of systemic lupus erythematosus: a comprehensive systematic analysis and modelling study","volume":"82","author":"Tian","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026071714115875500_uxag040-B2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s12016-009-8192-4","article-title":"The unexplained female predominance of systemic lupus erythematosus: clues from genetic and cytokine studies","volume":"40","author":"Weckerle","year":"2011","journal-title":"Clin Rev Allergy Immunol"},{"key":"2026071714115875500_uxag040-B3","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/01.bor.0000240354.37927.dd","article-title":"Sex and systemic lupus erythematosus: the role of the sex hormones estrogen and prolactin on the regulation of autoreactive B cells","volume":"18","author":"Grimaldi","year":"2006","journal-title":"Curr Opin Rheumatol"},{"key":"2026071714115875500_uxag040-B4","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aap8855","article-title":"TLR7 escapes X chromosome inactivation in immune cells","volume":"3","author":"Souyris","year":"2018","journal-title":"Sci Immunol"},{"key":"2026071714115875500_uxag040-B5","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.cell.2023.12.037","article-title":"Xist ribonucleoproteins promote female sex-biased autoimmunity","volume":"187","author":"Dou","year":"2024","journal-title":"Cell"},{"key":"2026071714115875500_uxag040-B6","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/art.38239","article-title":"The incidence and prevalence of systemic lupus erythematosus, 2002-2004: the Georgia lupus registry","volume":"66","author":"Lim","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026071714115875500_uxag040-B7","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1002\/art.38720","article-title":"Prevalence and incidence of systemic lupus erythematosus in a population-based registry of American Indian and Alaska native people, 2007-2009","volume":"66","author":"Ferucci","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2026071714115875500_uxag040-B8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S0140-6736(10)61354-2","article-title":"Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Navarra","year":"2011","journal-title":"Lancet"},{"key":"2026071714115875500_uxag040-B9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1912196","article-title":"Trial of anifrolumab in active systemic lupus erythematosus","volume":"382","author":"Morand","year":"2020","journal-title":"N Engl J Med"},{"key":"2026071714115875500_uxag040-B10","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMc2107725","article-title":"CD19-Targeted CAR T cells in refractory systemic lupus erythematosus","volume":"385","author":"Mougiakakos","year":"2021","journal-title":"N Engl J Med"},{"key":"2026071714115875500_uxag040-B11","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"2026071714115875500_uxag040-B12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease\u2014A case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"},{"key":"2026071714115875500_uxag040-B13","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/s12276-024-01220-3","article-title":"Molecular mechanisms of circular RNA translation","volume":"56","author":"Hwang","year":"2024","journal-title":"Exp Mol Med"},{"key":"2026071714115875500_uxag040-B14","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrc.2017.99","article-title":"Non-coding RNA networks in cancer","volume":"18","author":"Anastasiadou","year":"2018","journal-title":"Nat Rev Cancer"},{"key":"2026071714115875500_uxag040-B15","doi-asserted-by":"crossref","first-page":"32925","DOI":"10.1038\/srep32925","article-title":"miR-24, miR-30b and miR-142-3p interfere with antigen processing and presentation by primary macrophages and dendritic cells","volume":"6","author":"Naqvi","year":"2016","journal-title":"Sci Rep"},{"key":"2026071714115875500_uxag040-B16","doi-asserted-by":"crossref","first-page":"2226492","DOI":"10.1080\/15592294.2023.2226492","article-title":"LncRNA NEAT1 promotes IL-6 secretion in monocyte-derived dendritic cells via sponging miR-365a-3p in systemic lupus erythematosus","volume":"18","author":"Xiang","year":"2023","journal-title":"Epigenetics"},{"key":"2026071714115875500_uxag040-B17","doi-asserted-by":"crossref","first-page":"23650","DOI":"10.18632\/oncotarget.15569","article-title":"Identification of long non-coding RNAs GAS5, linc0597 and lnc-DC in plasma as novel biomarkers for systemic lupus erythematosus","volume":"8","author":"Wu","year":"2017","journal-title":"Oncotarget"},{"key":"2026071714115875500_uxag040-B18","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.virusres.2014.09.014","article-title":"Elevated antinuclear antibodies and altered anti-Epstein-Barr virus immune responses","volume":"195","author":"Cuomo","year":"2015","journal-title":"Virus Res"},{"key":"2026071714115875500_uxag040-B19","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.3390\/ijms19072072","article-title":"The nefarious nexus of noncoding RNAs in cancer","volume":"19","author":"Anastasiadou","year":"2018","journal-title":"Int J Mol Sci"},{"key":"2026071714115875500_uxag040-B20","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41580-024-00818-9","article-title":"A guide to the biogenesis and functions of endogenous small non-coding RNAs in animals","volume":"26","author":"Jouravleva","year":"2025","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026071714115875500_uxag040-B21","doi-asserted-by":"crossref","first-page":"402","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of MicroRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"2026071714115875500_uxag040-B22","first-page":"7024","article-title":"MiR-146a relieves kidney injury in mice with systemic lupus erythematosus through regulating NF-\u03baB pathway","volume":"23","author":"Fu","year":"2019","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026071714115875500_uxag040-B23","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1002\/art.39485","article-title":"In vivo therapeutic success of MicroRNA-155 antagomir in a mouse model of lupus alveolar hemorrhage","volume":"68","author":"Zhou","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2026071714115875500_uxag040-B24","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1136\/ard.2010.139857","article-title":"Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression","volume":"70","author":"Stagakis","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"2026071714115875500_uxag040-B25","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.4049\/jimmunol.0904060","article-title":"MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1","volume":"184","author":"Pan","year":"2010","journal-title":"J Immunol"},{"key":"2026071714115875500_uxag040-B26","doi-asserted-by":"crossref","first-page":"430239","DOI":"10.1155\/2013\/430239","article-title":"MicroRNAs implicated in the immunopathogenesis of lupus nephritis","volume":"2013","author":"Chafin","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"2026071714115875500_uxag040-B27","doi-asserted-by":"crossref","first-page":"864","DOI":"10.3390\/ijms17060864","article-title":"The MicroRNA-21 in autoimmune diseases","volume":"17","author":"Wang","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2026071714115875500_uxag040-B28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1093\/jmcb\/mju003","article-title":"The p53\/miR-34 axis in development and disease","volume":"6","author":"Rokavec","year":"2014","journal-title":"J Mol Cell Biol"},{"key":"2026071714115875500_uxag040-B29","doi-asserted-by":"crossref","first-page":"10737","DOI":"10.3390\/ijms221910737","article-title":"MicroRNAs in lupus nephritis-role in disease pathogenesis and clinical applications","volume":"22","author":"So","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2026071714115875500_uxag040-B30","doi-asserted-by":"crossref","first-page":"6889","DOI":"10.1128\/JVI.07056-11","article-title":"The Epstein-Barr virus (EBV)-induced tumor suppressor microRNA MiR-34a is growth promoting in EBV-infected B cells","volume":"86","author":"Forte","year":"2012","journal-title":"J Virol"},{"key":"2026071714115875500_uxag040-B31","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/ni.3385","article-title":"The microRNA miR-148a functions as a critical regulator of B cell tolerance and autoimmunity","volume":"17","author":"Gonzalez-Martin","year":"2016","journal-title":"Nat Immunol"},{"key":"2026071714115875500_uxag040-B32","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1002\/art.30196","article-title":"MicroRNA-126 regulates DNA methylation in CD4+ T cells and contributes to systemic lupus erythematosus by targeting DNA methyltransferase 1","volume":"63","author":"Zhao","year":"2011","journal-title":"Arthritis Rheum"},{"key":"2026071714115875500_uxag040-B33","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1681\/ASN.2013020130","article-title":"MicroRNA-155 drives TH17 immune response and tissue injury in experimental crescentic GN","volume":"24","author":"Krebs","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"2026071714115875500_uxag040-B34","doi-asserted-by":"crossref","first-page":"113013","DOI":"10.1016\/j.intimp.2024.113013","article-title":"Inflammatory factor-mediated miR-155\/SOCS1 signaling axis leads to Treg impairment in systemic lupus erythematosus","volume":"141","author":"Yu","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"2026071714115875500_uxag040-B35","doi-asserted-by":"crossref","first-page":"20194","DOI":"10.1073\/pnas.1317632110","article-title":"Deletion of microRNA-155 reduces autoantibody responses and alleviates lupus-like disease in the fas(lpr) mouse","volume":"110","author":"Thai","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026071714115875500_uxag040-B36","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.3390\/ijms17081282","article-title":"MicroRNA-155 mediates augmented CD40 expression in bone marrow derived plasmacytoid dendritic cells in symptomatic lupus-prone NZB\/W F1 mice","volume":"17","author":"Yan","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2026071714115875500_uxag040-B37","doi-asserted-by":"crossref","first-page":"816","DOI":"10.4161\/auto.9064","article-title":"Regulation of autophagy by a beclin 1-targeted microRNA, miR-30a, in cancer cells","volume":"5","author":"Zhu","year":"2009","journal-title":"Autophagy"},{"key":"2026071714115875500_uxag040-B38","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1002\/art.37912","article-title":"MicroRNA-30a promotes B cell hyperactivity in patients with systemic lupus erythematosus by direct interaction with lyn","volume":"65","author":"Liu","year":"2013","journal-title":"Arthritis Rheum"},{"key":"2026071714115875500_uxag040-B39","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1177\/0961203314522335","article-title":"Differential expression pattern of microRNAs in CD4+ and CD19+ cells from asymptomatic patients with systemic lupus erythematosus","volume":"23","author":"Mart\u00ednez-Ramos","year":"2014","journal-title":"Lupus"},{"key":"2026071714115875500_uxag040-B40","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2249.2012.04676.x","article-title":"Decreased microRNA(miR)-145 and increased miR-224 expression in T cells from patients with systemic lupus erythematosus involved in lupus immunopathogenesis","volume":"171","author":"Lu","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"2026071714115875500_uxag040-B41","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1074\/jbc.M114.591420","article-title":"MicroRNA-146a and microRNA-146b regulate human dendritic cell apoptosis and cytokine production by targeting TRAF6 and IRAK1 proteins","volume":"290","author":"Park","year":"2015","journal-title":"J Biol Chem"},{"key":"2026071714115875500_uxag040-B42","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.24436","article-title":"MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins","volume":"60","author":"Tang","year":"2009","journal-title":"Arthritis Rheum"},{"key":"2026071714115875500_uxag040-B43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002128","article-title":"A functional variant in microRNA-146a promoter modulates its expression and confers disease risk for systemic lupus erythematosus","volume":"7","author":"Luo","year":"2011","journal-title":"PLoS Genet"},{"key":"2026071714115875500_uxag040-B44","doi-asserted-by":"crossref","DOI":"10.1177\/03946320231154998","article-title":"Crosstalk between miR-146a and pro-inflammatory cytokines in patients with systemic lupus erythematosus","volume":"37","author":"El-Akhras","year":"2023","journal-title":"Int J Immunopathol Pharmacol"},{"key":"2026071714115875500_uxag040-B45","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1182\/blood-2012-12-475087","article-title":"MicroRNA-146a regulates survival and maturation of human plasmacytoid dendritic cells","volume":"122","author":"Karrich","year":"2013","journal-title":"Blood"},{"key":"2026071714115875500_uxag040-B46","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1002\/art.34505","article-title":"Decreased microRNA-142-3p\/5p expression causes CD4+ T cell activation and B cell hyperstimulation in systemic lupus erythematosus","volume":"64","author":"Ding","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2026071714115875500_uxag040-B47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41419-018-0298-2","article-title":"miR-142-3p regulates autophagy by targeting ATG16L1 in thymic-derived regulatory T cell (tTreg)","volume":"9","author":"Lu","year":"2018","journal-title":"Cell Death Dis"},{"key":"2026071714115875500_uxag040-B48","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/embor.2008.224","article-title":"miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA","volume":"10","author":"Huang","year":"2009","journal-title":"EMBO Rep"},{"key":"2026071714115875500_uxag040-B49","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.1002\/art.34596","article-title":"Identification of microRNA-31 as a novel regulator contributing to impaired interleukin-2 production in T cells from patients with systemic lupus erythematosus","volume":"64","author":"Fan","year":"2012","journal-title":"Arthritis Rheum"},{"key":"2026071714115875500_uxag040-B50","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/mrd.22678","article-title":"Function and regulation of microRNA-31 in development and disease","volume":"83","author":"Stepicheva","year":"2016","journal-title":"Mol Reprod Dev"},{"key":"2026071714115875500_uxag040-B51","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13148-015-0063-7","article-title":"The role of microRNA-1246 in the regulation of B cell activation and the pathogenesis of systemic lupus erythematosus","volume":"7","author":"Luo","year":"2015","journal-title":"Clin Epigenetics"},{"key":"2026071714115875500_uxag040-B52","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3892\/mmr.2020.11166","article-title":"Downregulated miR-29a promotes B cell overactivation by upregulating Crk-like protein in systemic lupus erythematosus","volume":"22","author":"Shi","year":"2020","journal-title":"Mol Med Rep"},{"key":"2026071714115875500_uxag040-B53","doi-asserted-by":"crossref","DOI":"10.1002\/jgm.3326","article-title":"Circulating miR-181a and miR-223 expression with the potential value of biomarkers for the diagnosis of systemic lupus erythematosus and predicting lupus nephritis","volume":"23","author":"Abdul-Maksoud","year":"2021","journal-title":"J Gene Med"},{"key":"2026071714115875500_uxag040-B54","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.biopha.2018.01.119","article-title":"miR-125b is downregulated in systemic lupus erythematosus patients and inhibits autophagy by targeting UVRAG","volume":"99","author":"Cao","year":"2018","journal-title":"Biomed Pharmacother"},{"key":"2026071714115875500_uxag040-B55","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1002\/art.27632","article-title":"MicroRNA-125a contributes to elevated inflammatory chemokine RANTES levels via targeting KLF13 in systemic lupus erythematosus","volume":"62","author":"Zhao","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2026071714115875500_uxag040-B56","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","article-title":"Long non-coding RNAs: definitions, functions, challenges and recommendations","volume":"24","author":"Mattick","year":"2023","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2026071714115875500_uxag040-B57","doi-asserted-by":"crossref","first-page":"792884","DOI":"10.3389\/fimmu.2021.792884","article-title":"LncRNA expression profiles in systemic lupus erythematosus and rheumatoid arthritis: emerging biomarkers and therapeutic targets","volume":"12","author":"Wu","year":"2021","journal-title":"Front Immunol"},{"key":"2026071714115875500_uxag040-B58","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jaut.2016.07.012","article-title":"Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus","volume":"75","author":"Zhang","year":"2016","journal-title":"J Autoimmun"},{"key":"2026071714115875500_uxag040-B59","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1038\/s41467-019-09482-6","article-title":"The lncRNA Neat1 promotes activation of inflammasomes in macrophages","volume":"10","author":"Zhang","year":"2019","journal-title":"Nat Commun"},{"key":"2026071714115875500_uxag040-B60","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/1756-185X.13786","article-title":"Clinical significance of reduced expression of lncRNA TUG1 in the peripheral blood of systemic lupus erythematosus patients","volume":"23","author":"Cao","year":"2020","journal-title":"Int J Rheum Dis"},{"key":"2026071714115875500_uxag040-B61","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.3389\/fimmu.2018.02967","article-title":"Identification of LncRNA Linc00513 containing lupus-associated genetic variants as a novel regulator of interferon signaling pathway","volume":"9","author":"Xue","year":"2018","journal-title":"Front Immunol"},{"key":"2026071714115875500_uxag040-B62","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13075-015-0632-3","article-title":"Association of large intergenic noncoding RNA expression with disease activity and organ damage in systemic lupus erythematosus","volume":"17","author":"Wu","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2026071714115875500_uxag040-B63","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0961203319830493","article-title":"RNA-Seq of circular RNAs identified circPTPN22 as a potential new activity indicator in systemic lupus erythematosus","volume":"28","author":"Miao","year":"2019","journal-title":"Lupus"},{"key":"2026071714115875500_uxag040-B64","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/s13075-023-03150-3","article-title":"CircPTPN22 modulates T-cell activation by sponging miR-4689 to regulate S1PR1 expression in patients with systemic lupus erythematosus","volume":"25","author":"Jiang","year":"2023","journal-title":"Arthritis Res Ther"},{"key":"2026071714115875500_uxag040-B65","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13075-018-1618-8","article-title":"CircIBTK inhibits DNA demethylation and activation of AKT signaling pathway via miR-29b in peripheral blood mononuclear cells in systemic lupus erythematosus","volume":"20","author":"Wang","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2026071714115875500_uxag040-B66","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.omtn.2017.12.006","article-title":"circHLA-C plays an important role in lupus nephritis by sponging miR-150","volume":"10","author":"Luan","year":"2018","journal-title":"Mol Ther Nucleic Acids"},{"key":"2026071714115875500_uxag040-B67","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3389\/fimmu.2019.02281","article-title":"Hsa_circ_0000479 as a novel diagnostic biomarker of systemic lupus erythematosus","volume":"10","author":"Guo","year":"2019","journal-title":"Front Immunol"},{"key":"2026071714115875500_uxag040-B68","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.12659\/MSM.906507","article-title":"Low expression and clinical value of hsa_circ_0049224 and has_circ_0049220 in systemic lupus erythematous patients","volume":"24","author":"Zhang","year":"2018","journal-title":"Med Sci Monit"},{"key":"2026071714115875500_uxag040-B69","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1042\/CS20180403","article-title":"The down-regulation of hsa_circ_0012919, the sponge for miR-125a-3p, contributes to DNA methylation of CD11a and CD70 in CD4(+) T cells of systemic lupus erythematous","volume":"132","author":"Zhang","year":"2018","journal-title":"Clin Sci (Lond)"},{"key":"2026071714115875500_uxag040-B70","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/0961203320920706","article-title":"Hsa_circ_0012919 regulates expression of MDA5 by miR-125a-3p in CD4+ T cells of systemic lupus erythematous","volume":"29","author":"Zhang","year":"2020","journal-title":"Lupus"},{"key":"2026071714115875500_uxag040-B71","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13075-020-02404-8","article-title":"Hsa_circ_0123190 acts as a competitive endogenous RNA to regulate APLNR expression by sponging hsa-miR-483-3p in lupus nephritis","volume":"23","author":"Zhang","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"2026071714115875500_uxag040-B72","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.4049\/jimmunol.131.4.1797","article-title":"Epstein-Barr virus induces normal B cell responses but defective suppressor T cell responses in patients with systemic lupus erythematosus","volume":"131","author":"Tsokos","year":"1983","journal-title":"J Immunol"},{"key":"2026071714115875500_uxag040-B73","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.4049\/jimmunol.172.2.1287","article-title":"Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus","volume":"172","author":"Kang","year":"2004","journal-title":"J Immunol"},{"key":"2026071714115875500_uxag040-B74","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000015","article-title":"Reduced response to Epstein-Barr virus antigens by T-cells in systemic lupus erythematosus patients","volume":"1","author":"Draborg","year":"2014","journal-title":"Lupus Sci Med"},{"key":"2026071714115875500_uxag040-B75","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s10238-018-0535-0","article-title":"The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis","volume":"19","author":"Li","year":"2019","journal-title":"Clin Exp Med"},{"key":"2026071714115875500_uxag040-B76","doi-asserted-by":"crossref","first-page":"100117","DOI":"10.1016\/j.jtauto.2021.100117","article-title":"Serologic markers of Epstein-Barr virus reactivation are associated with increased disease activity, inflammation, and interferon pathway activation in patients with systemic lupus erythematosus","volume":"4","author":"Wood","year":"2021","journal-title":"J Transl Autoimmun"},{"key":"2026071714115875500_uxag040-B77","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1136\/annrheumdis-2019-215361","article-title":"Association of Epstein-Barr virus serological reactivation with transitioning to systemic lupus erythematosus in at-risk individuals","volume":"78","author":"Jog","year":"2019","journal-title":"Ann Rheum Dis"},{"key":"2026071714115875500_uxag040-B78","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1307589","article-title":"Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus","volume":"14","author":"Banko","year":"2023","journal-title":"Front Immunol"},{"key":"2026071714115875500_uxag040-B79","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1002\/eji.1830230525","article-title":"Autoantibodies from patients with systemic lupus erythematosus bind a shared sequence of SmD and Epstein-Barr virus-encoded nuclear antigen EBNA I","volume":"23","author":"Sabbatini","year":"1993","journal-title":"Eur J Immunol"},{"key":"2026071714115875500_uxag040-B80","doi-asserted-by":"crossref","first-page":"425","DOI":"10.3389\/fimmu.2015.00425","article-title":"Defects in germinal center selection in SLE","volume":"6","author":"Woods","year":"2015","journal-title":"Front Immunol"},{"key":"2026071714115875500_uxag040-B81","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/BOR.0b013e32832e089e","article-title":"Type I interferon and lupus","volume":"21","author":"R\u00f6nnblom","year":"2009","journal-title":"Curr Opin Rheumatol"},{"key":"2026071714115875500_uxag040-B82","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/jir.2011.0045","article-title":"Type I interferon and systemic lupus erythematosus","volume":"31","author":"Elkon","year":"2011","journal-title":"J Interferon Cytokine Res"},{"key":"2026071714115875500_uxag040-B83","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009599","article-title":"60 kD Ro and nRNP A frequently initiate human lupus autoimmunity","volume":"5","author":"Heinlen","year":"2010","journal-title":"PLoS One"},{"key":"2026071714115875500_uxag040-B84","doi-asserted-by":"crossref","first-page":"606936","DOI":"10.3389\/fimmu.2020.606936","article-title":"Epstein-Barr functional mimicry: pathogenicity of oncogenic latent membrane protein-1 in systemic lupus erythematosus and autoimmunity","volume":"11","author":"Munroe","year":"2021","journal-title":"Front Immunol"},{"key":"2026071714115875500_uxag040-B85","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/art.21682","article-title":"An altered immune response to Epstein-Barr nuclear antigen 1 in pediatric systemic lupus erythematosus","volume":"54","author":"McClain","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2026071714115875500_uxag040-B86","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.ady0210","article-title":"Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus","volume":"17","author":"Younis","year":"2025","journal-title":"Sci Transl Med"},{"key":"2026071714115875500_uxag040-B87","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/s41588-018-0102-3","article-title":"Transcription factors operate across disease loci, with EBNA2 implicated in autoimmunity","volume":"50","author":"Harley","year":"2018","journal-title":"Nat Genet"},{"key":"2026071714115875500_uxag040-B88","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005339","article-title":"EBNA2 drives formation of new chromosome binding sites and target genes for B-cell master regulatory transcription factors RBP-j\u03ba and EBF1","volume":"12","author":"Lu","year":"2016","journal-title":"PLoS Pathog"},{"key":"2026071714115875500_uxag040-B89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0898-6568(02)00083-9","article-title":"CD40 and its viral mimic, LMP1: similar means to different ends","volume":"15","author":"Lam","year":"2003","journal-title":"Cell Signal"},{"key":"2026071714115875500_uxag040-B90","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/0961203317753069","article-title":"Epstein-Barr virus infection and type I interferon signature in patients with systemic lupus erythematosus","volume":"27","author":"Han","year":"2018","journal-title":"Lupus"},{"key":"2026071714115875500_uxag040-B91","article-title":"The oxysterol receptor EBI2 links innate and adaptive immunity to limit IFN response and systemic lupus erythematosus","volume":"10","author":"Zhang","year":"2023","journal-title":"Adv Sci (Weinh)"},{"key":"2026071714115875500_uxag040-B92","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3390\/cancers16050991","article-title":"Epigenetic mechanisms in latent Epstein-Barr virus infection and associated cancers","volume":"16","author":"Torne","year":"2024","journal-title":"Cancers (Basel)"},{"key":"2026071714115875500_uxag040-B93","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1073\/pnas.78.2.805","article-title":"Two small RNAs encoded by Epstein-Barr virus and complexed with protein are precipitated by antibodies from patients with systemic lupus erythematosus","volume":"78","author":"Lerner","year":"1981","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026071714115875500_uxag040-B94","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3892\/etm.2014.1578","article-title":"The expression of renal Epstein-Barr virus markers in patients with lupus nephritis","volume":"7","author":"Yu","year":"2014","journal-title":"Exp Ther Med"},{"key":"2026071714115875500_uxag040-B95","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/art.27408","article-title":"Epstein-Barr virus promotes interferon-alpha production by plasmacytoid dendritic cells","volume":"62","author":"Quan","year":"2010","journal-title":"Arthritis Rheum"},{"key":"2026071714115875500_uxag040-B96","doi-asserted-by":"crossref","first-page":"6328","DOI":"10.1073\/pnas.0914843107","article-title":"Functional delivery of viral miRNAs via exosomes","volume":"107","author":"Pegtel","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026071714115875500_uxag040-B97","doi-asserted-by":"crossref","first-page":"101272","DOI":"10.1016\/j.coviro.2022.101272","article-title":"MicroRNA-mediated control of Epstein-Barr virus infection and potential diagnostic and therapeutic implications","volume":"56","author":"Skalsky","year":"2022","journal-title":"Curr Opin Virol"},{"key":"2026071714115875500_uxag040-B98","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1126\/science.1141229","article-title":"Regulation of the germinal center response by microRNA-155","volume":"316","author":"Thai","year":"2007","journal-title":"Science"},{"key":"2026071714115875500_uxag040-B99","doi-asserted-by":"crossref","first-page":"10025","DOI":"10.1007\/s11033-023-08845-z","article-title":"Serum miRNA-21, miRNA-146a and plasma cell free DNA as novel biomarkers for assessing systemic lupus erythematosus activity","volume":"50","author":"Ibrahim","year":"2023","journal-title":"Mol Biol Rep"},{"key":"2026071714115875500_uxag040-B100","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1038\/leu.2012.108","article-title":"Differential regulation of miR-21 and miR-146a by Epstein-Barr virus-encoded EBNA2","volume":"26","author":"Rosato","year":"2012","journal-title":"Leukemia"},{"key":"2026071714115875500_uxag040-B101","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1038\/s41375-018-0178-x","article-title":"Epstein-Barr virus-encoded EBNA2 alters immune checkpoint PD-L1 expression by downregulating miR-34a in B-cell lymphomas","volume":"33","author":"Anastasiadou","year":"2019","journal-title":"Leukemia"},{"key":"2026071714115875500_uxag040-B102","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1182\/blood.2023021346","article-title":"Epstein-Barr virus-encoded EBNA2 downregulates ICOSL by inducing miR-24 in B-cell lymphoma","volume":"143","author":"Leopizzi","year":"2024","journal-title":"Blood"},{"key":"2026071714115875500_uxag040-B103","doi-asserted-by":"crossref","DOI":"10.1186\/1546-0096-10-S1-A2","article-title":"PD-L1 expression on monocytes marks active systemic lupus erythematosus in patients without nephritis","volume":"10","author":"Stevens","year":"2012","journal-title":"Pediatr Rheumatol Online J"},{"key":"2026071714115875500_uxag040-B104","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.3389\/fimmu.2025.1539373","article-title":"Case report: subacute cutaneous lupus erythematosus induced by the anti-PD-1 antibody camrelizumab combined with chemotherapy","volume":"16","author":"Bao","year":"2025","journal-title":"Front Immunol"},{"key":"2026071714115875500_uxag040-B105","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2016-000146","article-title":"Inducible T-cell co-stimulator ligand (ICOSL) blockade leads to selective inhibition of anti-KLH IgG responses in subjects with systemic lupus erythematosus","volume":"3","author":"Sullivan","year":"2016","journal-title":"Lupus Sci Med"},{"key":"2026071714115875500_uxag040-B106","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/s12935-021-01986-w","article-title":"Long non-coding RNAs in Epstein-Barr virus-related cancer","volume":"21","author":"Liu","year":"2021","journal-title":"Cancer Cell Int"},{"key":"2026071714115875500_uxag040-B107","author":"Shibusawa"},{"key":"2026071714115875500_uxag040-B108","doi-asserted-by":"crossref","first-page":"623944","DOI":"10.3389\/fimmu.2020.623944","article-title":"Epstein Barr Virus and autoimmune responses in systemic lupus erythematosus","volume":"11","author":"Jog","year":"2021","journal-title":"Front Immunol"},{"key":"2026071714115875500_uxag040-B109","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1038\/s41375-022-01804-w","article-title":"Molecular profiling of EBV associated diffuse large B-cell lymphoma","volume":"37","author":"Frontzek","year":"2023","journal-title":"Leukemia"},{"key":"2026071714115875500_uxag040-B110","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/ard-2024-225785","article-title":"BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial","volume":"83","author":"Wang","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"2026071714115875500_uxag040-B111","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2025.103369","article-title":"CAR-T cell targeting three receptors on autoreactive B cells for systemic lupus erythematosus therapy","volume":"151","author":"Uppin","year":"2025","journal-title":"J Autoimmun"},{"key":"2026071714115875500_uxag040-B112","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.aaf6756","article-title":"Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease","volume":"353","author":"Ellebrecht","year":"2016","journal-title":"Science"},{"key":"2026071714115875500_uxag040-B113","doi-asserted-by":"crossref","first-page":"1465191","DOI":"10.3389\/fimmu.2024.1465191","article-title":"Application of novel CAR technologies to improve treatment of autoimmune disease","volume":"15","author":"Cheever","year":"2024","journal-title":"Front Immunol"},{"key":"2026071714115875500_uxag040-B114","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1038\/s41587-022-01637-z","article-title":"Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells","volume":"41","author":"Oh","year":"2023","journal-title":"Nat Biotechnol"},{"key":"2026071714115875500_uxag040-B115","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-008888","article-title":"Off-the-shelf CAR-NK cells targeting immunogenic cell death marker ERp57 execute robust antitumor activity and have a synergistic effect with ICD inducer oxaliplatin","volume":"12","author":"Zheng","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026071714115875500_uxag040-B116","doi-asserted-by":"crossref","first-page":"101385","DOI":"10.1016\/j.omtm.2024.101385","article-title":"High affinity chimeric antigen receptor signaling induces an inflammatory program in human regulatory T cells","volume":"32","author":"Cochrane","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"2026071714115875500_uxag040-B117","doi-asserted-by":"crossref","first-page":"1795760","DOI":"10.3389\/fimmu.2026.1795760","article-title":"Advances in understanding the Th17\/Treg balance in systemic lupus erythematosus: implications for treatment and management","volume":"17","author":"Liu","year":"2026","journal-title":"Front Immunol"},{"key":"2026071714115875500_uxag040-B118","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1126\/science.ads8473","article-title":"In vivo CAR T cell generation to treat cancer and autoimmune disease","volume":"388","author":"Hunter","year":"2025","journal-title":"Science"},{"key":"2026071714115875500_uxag040-B119","doi-asserted-by":"crossref","DOI":"10.1002\/cti2.70015","article-title":"Autologous Epstein-Barr virus-specific adoptive T-cell therapy in a patient with lupus nephritis","volume":"13","author":"Ranganathan","year":"2024","journal-title":"Clin Transl Immunology"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cei\/advance-article-pdf\/doi\/10.1093\/cei\/uxag040\/68764591\/uxag040.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/220\/1\/uxag040\/68764591\/uxag040.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/220\/1\/uxag040\/68764591\/uxag040.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T18:12:17Z","timestamp":1784311937000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/doi\/10.1093\/cei\/uxag040\/8733301"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":119,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,6]]}},"URL":"https:\/\/doi.org\/10.1093\/cei\/uxag040","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"uxag040"}}